Skip to main content
SpringerLink
Log in
Book cover

Radiation Therapy for Extranodal Lymphomas pp 15–28Cite as

Ocular Adnexal Lymphoma

  • Chapter
  • First Online:

  • 609 Accesses

Abstract

Ocular adnexal lymphomas arise from the orbital structure, including the conjunctiva, eyelid, lacrimal gland, and retrobulbar region. The majority of ocular adnexal lymphomas are extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT lymphoma), which usually tend to remain localized for a long time and have an indolent natural history. Among various treatment options for localized ocular adnexal MALT lymphoma, such as chemotherapy, rituximab, antibiotic therapy, surgery, and watchful waiting, radiation therapy alone is the most promising modality as the definitive treatment. Moderate doses (24–30 Gy) of radiation therapy are safe and can achieve local control in greater than 95% of the patients. To avoid severe and incurable adverse events on the eyes, doses higher than 30 Gy should not be delivered for MALT lymphoma. Localized diffuse large B-cell lymphomas (DLBCL), which comprise a minority of primary ocular adnexal lymphomas, are commonly treated with a combined modality therapy consisting of chemotherapy with rituximab followed by radiation therapy. For DLBCL, a dose of 30 Gy is recommended for patients who had a complete response to immunochemotherapy. In the case of electron beam therapy for conjunctival lymphoma, lens shielding can effectively reduce the risk of cataract formation.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252–60.

    Article  CAS  PubMed  Google Scholar 

  2. Ohtsuka K, Hashimoto M, Suzuki Y. A review of 244 orbital tumors in Japanese patients during a 21-year period: origins and locations. Jpn J Ophthalmol. 2005;49:49–55.

    Article  PubMed  Google Scholar 

  3. Cho EY, Han JJ, Ree HJ, Ko YH, Kang YK, Ahn HS, et al. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Am J Hematol. 2003;73:87–96.

    Article  PubMed  Google Scholar 

  4. Stefanovic A, Lossos IS. Extranodal marginal zone lymphoma of the ocular adnexa. Blood. 2009;114:501–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Munch-Petersen HD, Rasmussen PK, Coupland SE, Esmaeli B, Finger PT, Graue GF, et al. Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study. JAMA Ophthalmol. 2015;133:165–73. doi:10.1001/jamaophthalmol.2014.4644.

    Article  PubMed  Google Scholar 

  6. Isaacson PG, Chott A, Nakamura S, Muller-Hermelink HK, Harris NL, Swerdlow SH. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. World health organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 214–7.

    Google Scholar 

  7. Coupland SE, Hellmich M, Auw-Haedrich C, Lee WR, Anagnostopoulos I, Stein H. Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases. Br J Ophthalmol. 2005;89:352–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ruiz A, Reischl U, Swerdlow SH, Hartke M, Streubel B, Procop G, et al. Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci. Am J Surg Pathol. 2007;31:792–802.

    Article  PubMed  Google Scholar 

  9. Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood. 2000;95:802–6.

    CAS  PubMed  Google Scholar 

  10. Bayraktar S, Bayraktar UD, Stefanovic A, Lossos IS. Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients. Br J Haematol. 2011;152:72–80. doi:10.1111/j.1365-2141.2010.08429.x.

    Article  PubMed  Google Scholar 

  11. Ferry JA, Fung CY, Zukerberg L, Lucarelli MJ, Hasserjian RP, Preffer FI, et al. Lymphoma of the ocular adnexa: A study of 353 cases. Am J Surg Pathol. 2007;31:170–84.

    Article  PubMed  Google Scholar 

  12. Teckie S, Qi S, Lovie S, Navarrett S, Hsu M, Noy A, et al. Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent. Int J Radiat Oncol Biol Phys. 2015;92:130–7. doi:10.1016/j.ijrobp.2015.01.040.

    Article  PubMed  Google Scholar 

  13. Tanimoto K, Kaneko A, Suzuki S, Sekiguchi N, Watanabe T, Kobayashi Y, et al. Primary ocular adnexal MALT lymphoma: a long-term follow-up study of 114 patients. Jpn J Clin Oncol. 2007;37:337–44.

    Article  PubMed  Google Scholar 

  14. Goda JS, Le LW, Lapperriere NJ, Millar BA, Payne D, Gospodarowicz MK, et al. Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity. Int J Radiat Oncol Biol Phys. 2011;81:e659–66. doi:10.1016/j.ijrobp.2011.03.050.

    Article  PubMed  Google Scholar 

  15. Woolf DK, Kuhan H, Shoffren O, Akinnawo EM, Sivagurunathan B, Boyce H, et al. Outcomes of primary lymphoma of the ocular adnexa (orbital lymphoma) treated with radiotherapy. Clin Oncol (R Coll Radiol). 2015;27:153–9. doi:10.1016/j.clon.2014.10.002.

    Article  CAS  PubMed  Google Scholar 

  16. Ferreri AJ. Risk of CNS dissemination in extranodal lymphomas. Lancet Oncol. 2014;15:e159–69. doi:10.1016/S1470-2045(13)70568-0.

    Article  PubMed  Google Scholar 

  17. Ponzoni M, Govi S, Licata G, Mappa S, Giordano Resti A, Politi LS, et al. A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma. Oncologist. 2013;18:876–84. doi:10.1634/theoncologist.2012-0425.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Treglia G, Zucca E, Sadeghi R, Cavalli F, Giovanella L, Ceriani L. Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis. Hematol Oncol. 2015;33:113–24. doi:10.1002/hon.2152.

    Article  PubMed  Google Scholar 

  19. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–68.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Uno T, Isobe K, Shikama N, Nishikawa A, Oguchi M, Ueno N, et al. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients. Cancer. 2003;98:865–71.

    Article  PubMed  Google Scholar 

  21. Husain A, Roberts D, Pro B, McLaughlin P, Esmaeli B. Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics. Cancer. 2007;110:809–15.

    Article  PubMed  Google Scholar 

  22. Pfeffer MR, Rabin T, Tsvang L, Goffman J, Rosen N, Symon Z. Orbital lymphoma: is it necessary to treat the entire orbit? Int J Radiat Oncol Biol Phys. 2004;60:527–30.

    Article  PubMed  Google Scholar 

  23. Yahalom J, Illidge T, Specht L, Hoppe RT, Li YX, Tsang R, et al. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2015;92:11–31. doi:10.1016/j.ijrobp.2015.01.009.

    Article  PubMed  Google Scholar 

  24. Tran KH, Campbell BA, Fua T, MacManus M, Ryan G, Chesson B, Wirth A. Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma. Leuk Lymphoma. 2013;54:491–6. doi:10.3109/10428194.2012.717279.

    Article  PubMed  Google Scholar 

  25. Haas RL, Poortmans P, de Jong D, Aleman BM, Dewit LG, Verheij M, et al. High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J Clin Oncol. 2003;21:2474–80.

    Article  CAS  PubMed  Google Scholar 

  26. Fasola CE, Jones JC, Huang DD, Le QT, Hoppe RT, Donaldson SS. Low-dose radiation therapy (2 Gy × 2) in the treatment of orbital lymphoma. Int J Radiat Oncol Biol Phys. 2013;86(5):930. doi:10.1016/j.ijrobp.2013.04.035.

    Article  PubMed  Google Scholar 

  27. Suh CO, Shim SJ, Lee SW, Yang WI, Lee SY, Hahn JS. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior. Int J Radiat Oncol Biol Phys. 2006;65:228–33.

    Article  PubMed  Google Scholar 

  28. Ejima Y, Sasaki R, Okamoto Y, Maruta T, Azumi A, Hayashi Y, et al. Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy. Radiother Oncol. 2006;78(1):6–9.

    Article  PubMed  Google Scholar 

  29. Le QT, Eulau SM, George TI, Hildebrand R, Warnke RA, Donaldson SS, Hoppe RT. Primary radiotherapy for localized orbital MALT lymphoma. Int J Radiat Oncol Biol Phys. 2002;52:657–63.

    Article  PubMed  Google Scholar 

  30. Olszewski AJ, Desai A. Radiation therapy administration and survival in stage I/II extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Int J Radiat Oncol Biol Phys. 2014;88:642–9. doi:10.1016/j.ijrobp.2013.11.225.

    Article  PubMed  Google Scholar 

  31. Zucca E, Conconi A, Laszlo D, López-Guillermo A, Bouabdallah R, Coiffier B, et al. Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study. J Clin Oncol. 2013;31:565–72. doi:10.1200/JCO.2011.40.6272.

    Article  CAS  PubMed  Google Scholar 

  32. Wöhrer S, Kiesewetter B, Fischbach J, Müllauer L, Troch M, Lukas J, et al. Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis. Ann Hematol. 2014;93:1287–95. doi:10.1007/s00277-014-2042-z.

    Article  PubMed  Google Scholar 

  33. Harada K, Murakami N, Kitaguchi M, Sekii S, Takahashi K, Yoshio K, et al. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes. Int J Radiat Oncol Biol Phys. 2014;88:650–4. doi:10.1016/j.ijrobp.2013.11.235.

    Article  PubMed  Google Scholar 

  34. Hata M, Omura M, Koike I, Tomita N, Iijima Y, Tayama Y, et al. Treatment effects and sequelae of radiation therapy for orbital mucosa-associated lymphoid tissue lymphoma. Int J Radiat Oncol Biol Phys. 2011;81:1387–93. doi:10.1016/j.ijrobp.2010.07.1992.

    Article  PubMed  Google Scholar 

  35. Kaushik M, Pulido JS, Schild SE, Stafford S. Risk of radiation retinopathy in patients with orbital and ocular lymphoma. Int J Radiat Oncol Biol Phys. 2012;84:1145–50.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Radiation Oncology, Kobe University Hospital, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo, Japan

    Yasuo Ejima

Authors
  1. Yasuo Ejima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasuo Ejima .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Juntendo University Faculty of Medicine, Tokyo, Japan

    Keisuke Sasai

  2. Department of Radiation Oncology, The Cancer Institute Hospital, Tokyo, Japan

    Masahiko Oguchi

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Japan

About this chapter

Cite this chapter

Ejima, Y. (2017). Ocular Adnexal Lymphoma. In: Sasai, K., Oguchi, M. (eds) Radiation Therapy for Extranodal Lymphomas. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56435-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-56435-5_2

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-56433-1

  • Online ISBN: 978-4-431-56435-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation